Background Cancer-related anemia (CRA) is the most common hematologic complication of malignant tumors and their treatments, affecting treatment delivery, quality of life and survival. A macro-level map of the field’s knowledge structure, evolution and frontiers is still lacking. Methods Publications on CRA published b...
Long-Jun Huang, Lui Chi, Jia-Hao Sheng et al.· Frontiers in Oncology· 0 citations
may assist pseudoprogression interpretation, while RECIST maintains superiority in standardization, regulatory acceptance, and spatial resolution. Based on these complementary characteristics, we propose a ctDNA-enhanced RECIST framework (C) , in which ctDNA serves as an adjunct across three clinical scenarios: early e...
Jian-Shan Zheng, Lui Chi, Yong Guo· Frontiers in Oncology· 0 citations
Clonal hematopoiesis of indeterminate potential (CHIP), the age-related expansion of hematopoietic stem cells carrying leukemia-associated somatic mutations, is common in patients with cancer and is increasingly detected during tumor-only genomic profiling and cell-free DNA sequencing. In this narrative review, we asse...
Long-Jun Huang, Jia-Hao Sheng, Lui Chi et al.· Frontiers in Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.